EMG
IOVA icon

Ellington Management Group’s Iovance Biotherapeutics IOVA Stock Holding History

Ellington Management Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25,394
Closed -$241K – 679
2019
Q1 		$241K Buy
+25,394
New +$247K 0.05% 424
2018
Q1 		– Sell
-19,200
Closed -$154K – 922
2017
Q4 		$154K Buy
19,200
+5,400
+39% +$43.4K 0.04% 524
2017
Q3 		$107K Sell
13,800
-17,800
-56% -$113K 0.03% 585
2017
Q2 		$232K Buy
+31,600
New +$201K 0.06% 489
2016
Q4 		– Sell
-12,400
Closed -$102K – 669
2016
Q3 		$102K Buy
+12,400
New +$105K 0.03% 614
2016
Q2 		– Sell
-34,600
Closed -$176K – 363
2016
Q1 		$176K Buy
+34,600
New +$189K 0.08% 419

Other funds holding IOVA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return